A cyclic metastasis-homing peptide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BLMP6 (trifluoroacetate salt)

Item No. 46267

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
(4R,10S,16S,22S,25S,28R)-28-amino-10,25-bis(3-guanidinopropyl)-16-isopropyl-22-methyl-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octaazacyclononacosane-4-carboxylic acid, trifluoroacetate salt
Synonyms
  • Breast Lung Metastasis-homing Peptide 6
  • cyclo(Cys-Arg-Ala-Gly-Val-Gly-Arg-Gly-Cys)-OH
Molecular Formula
C32H57N15O10S2 • XCF3COOH
Formula Weight
876.0
Purity
≥95%
Formulation (Request formulation change)
A solid
Peptide Sequence
[CRAGVGRGC]-OH
Solubility(Learn about Variance in Solubility)
DMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/mlPBS, pH 7.2: Soluble: ≥10 mg/ml
SMILES
O=C([C@@H](N)CSSC[C@@H](C(O)=O)N1)N[C@H](C(N[C@@H](C)C(NCC(N[C@H](C(NCC(N[C@H](C(NCC1=O)=O)CCCNC(N)=N)=O)=O)C(C)C)=O)=O)=O)CCCNC(N)=N.O=C(O)C(F)(F)F
InChi Code
InChI=1S/C32H57N15O10S2.C2HF3O2/c1-15(2)24-29(55)42-11-21(48)44-18(6-4-8-38-31(34)35)27(53)41-10-22(49)45-20(30(56)57)14-59-58-13-17(33)26(52)46-19(7-5-9-39-32(36)37)28(54)43-16(3)25(51)40-12-23(50)47-24;3-2(4,5)1(6)7/h15-20,24H,4-14,33H2,1-3H3,(H,40,51)(H,41,53)(H,42,55)(H,43,54)(H,44,48)(H,45,49)(H,46,52)(H,47,50)(H,56,57)(H4,34,35,38)(H4,36,37,39);(H,6,7)/t16-,17-,18-,19-,20-,24-;/m0./s1
InChi Key
CRKGBKPTWJKEJN-XPXZCRDWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $275

    Add

    5 mg

    $756

    Add

    10 mg

    $1,100

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    BLMP6 is a cyclic metastasis-homing peptide.1 It mimics the EGF-like calcium-binding domain 6 of latent TGF-β-binding protein 4 (LTBP4) and selectively binds to fibulin-4 (FIBL-4) over FIBL-3 (Kds = 0.318 and 635 µM, respectively). Fluorescently labeled BLMP6 selectively labels metastatic breast cancer biopsies over adjacent control breast tissue and non-ductal breast cancer biopsies in human tissue arrays.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Daquinag, A.C., Ghosh, S.C., AghaAmiri, S., et al. Fibulin-4 expressed in metastatic breast cancer is a target of peptide-based imaging probes and experimental therapeutics. Mol. Ther. Oncol. 34(2), 201207 (2026).